BC
ONC

Brinker Capital’s BeOne Medicines Ltd ONC Stock Holding History

Brinker Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$761K Buy
4,039
+131
+3% +$21.3K 0.02% 586
2020
Q1 		$481K Sell
3,908
-205
-5% -$32.1K 0.02% 652
2019
Q4 		$682K Buy
4,113
+82
+2% +$13.6K 0.02% 631
2019
Q3 		$494K Buy
4,031
+362
+10% +$48.1K 0.02% 705
2019
Q2 		$455K Sell
3,669
-214
-6% -$27.2K 0.02% 704
2019
Q1 		$513K Buy
3,883
+1,210
+45% +$163K 0.02% 677
2018
Q4 		$375K Sell
2,673
-1,139
-30% -$151K 0.02% 679
2018
Q3 		$657K Buy
+3,812
New +$641K 0.02% 626

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Brinker Capital's ONC Position: Q2 2020 in Review

Brinker Capital increased its BeOne Medicines Ltd (ONC) stake by 3.4% in Q2 2020, buying an estimated $21.3K and bringing the position to 4,039 shares worth $761K. The position accounts for 0.02% of the portfolio, ranked #586.

Brinker Capital first reported a position in ONC in Q3 2018 and has held it in 8 quarters since. 220 funds tracked by Wall St. Rank hold ONC as of Q2 2020.

  • Brinker Capital held 4,039 shares of BeOne Medicines Ltd worth $761K as of Q2 2020.
  • Brinker Capital bought 131 BeOne Medicines Ltd shares in Q2 2020, an estimated $21.3K.
  • BeOne Medicines Ltd made up 0.02% of Brinker Capital's portfolio in Q2 2020, its #586 holding.
  • Brinker Capital first reported a position in BeOne Medicines Ltd in Q3 2018 and has held it in 8 quarters since.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.